Header Logo

Eric Ko

Concepts (205)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy
6
2023
202
2.610
Why?
Radiotherapy
3
2019
48
1.950
Why?
Carcinoma, Non-Small-Cell Lung
3
2020
114
1.880
Why?
Head and Neck Neoplasms
5
2023
66
1.620
Why?
Prostatic Neoplasms
4
2017
288
1.310
Why?
Prostate-Specific Antigen
4
2017
53
1.160
Why?
Lung Neoplasms
3
2020
494
1.080
Why?
Combined Modality Therapy
7
2023
293
1.010
Why?
Brachytherapy
3
2013
39
0.880
Why?
Neoplasms
5
2019
1118
0.620
Why?
Radiotherapy, Intensity-Modulated
3
2012
19
0.610
Why?
Prostatectomy
2
2017
49
0.600
Why?
Adenocarcinoma
2
2011
333
0.560
Why?
Neoplasm Metastasis
5
2019
185
0.520
Why?
Neoplasm Staging
5
2018
410
0.500
Why?
Carcinoma, Squamous Cell
2
2014
146
0.480
Why?
Kallikreins
1
2013
7
0.480
Why?
Androgen Antagonists
1
2013
14
0.480
Why?
Induction Chemotherapy
1
2011
27
0.410
Why?
Radiation Injuries
1
2010
48
0.350
Why?
Antibodies, Monoclonal
6
2020
774
0.320
Why?
Antigens, Neoplasm
5
2006
123
0.310
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
1
2007
3
0.310
Why?
Humans
25
2023
52915
0.310
Why?
Immunotherapy, Adoptive
1
2007
56
0.300
Why?
Melanoma, Experimental
1
2007
43
0.300
Why?
Radiosurgery
2
2019
48
0.290
Why?
Antineoplastic Agents
4
2017
532
0.290
Why?
Endothelial Cells
1
2007
162
0.270
Why?
Clinical Trials as Topic
2
2018
379
0.270
Why?
Colonic Neoplasms
1
2007
193
0.270
Why?
Pyrroles
3
2015
45
0.260
Why?
Dendritic Cells
2
2007
491
0.260
Why?
Indoles
3
2015
83
0.250
Why?
Tumor Microenvironment
2
2019
122
0.250
Why?
Immunotherapy, Active
1
2003
4
0.240
Why?
Epitopes
3
2019
291
0.240
Why?
Immunization, Passive
1
2003
90
0.230
Why?
Myeloid Cells
2
2015
85
0.210
Why?
Treatment Outcome
5
2018
4221
0.210
Why?
Patient Selection
1
2023
368
0.200
Why?
CD8-Positive T-Lymphocytes
3
2019
647
0.200
Why?
Survival Analysis
3
2012
474
0.200
Why?
Breast Neoplasms
1
2010
1093
0.190
Why?
Antibodies, Monoclonal, Humanized
2
2020
185
0.190
Why?
Middle Aged
9
2017
14048
0.190
Why?
Antineoplastic Agents, Immunological
1
2020
35
0.180
Why?
Aged, 80 and over
6
2017
4468
0.180
Why?
CTLA-4 Antigen
1
2019
62
0.170
Why?
Radiotherapy, Adjuvant
2
2016
52
0.170
Why?
Male
10
2017
24092
0.170
Why?
Antigens
1
2019
138
0.170
Why?
Radium
1
2017
1
0.160
Why?
Tissue Extracts
1
2017
10
0.160
Why?
Aged
7
2017
11575
0.160
Why?
Prostatic Neoplasms, Castration-Resistant
1
2017
5
0.160
Why?
Taxoids
1
2017
21
0.160
Why?
Tumor Burden
1
2017
60
0.150
Why?
Organophosphorus Compounds
1
2017
30
0.150
Why?
Salvage Therapy
1
2017
48
0.150
Why?
Receptors, Antigen, T-Cell
1
2019
275
0.150
Why?
Treatment Failure
2
2017
174
0.150
Why?
Organometallic Compounds
1
2017
58
0.150
Why?
Radiotherapy Dosage
2
2014
64
0.150
Why?
Neoplasm Grading
2
2017
60
0.140
Why?
Antibodies, Neoplasm
2
2006
20
0.140
Why?
Survival Rate
3
2017
665
0.130
Why?
CD4-Positive T-Lymphocytes
3
2015
579
0.130
Why?
Neoplasms, Squamous Cell
1
2014
5
0.120
Why?
T-Lymphocytes, Cytotoxic
2
2006
149
0.120
Why?
New York City
1
2013
69
0.120
Why?
Retrospective Studies
3
2014
5134
0.120
Why?
Melanoma
3
2006
326
0.120
Why?
Risk Factors
3
2014
4475
0.120
Why?
Disease-Free Survival
1
2013
183
0.110
Why?
Randomized Controlled Trials as Topic
1
2016
562
0.110
Why?
Robotic Surgical Procedures
1
2014
76
0.110
Why?
Radiation-Sensitizing Agents
1
2012
7
0.110
Why?
Radiotherapy, Image-Guided
1
2012
6
0.110
Why?
Chemoradiotherapy
1
2012
23
0.110
Why?
Small Molecule Libraries
1
2012
49
0.100
Why?
Drug Evaluation, Preclinical
1
2012
80
0.100
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2012
49
0.100
Why?
Palladium
1
2011
5
0.100
Why?
Radioisotopes
1
2011
22
0.100
Why?
Molecular Mimicry
3
2006
35
0.100
Why?
Iodine Radioisotopes
1
2011
53
0.100
Why?
Binding Sites, Antibody
3
2006
30
0.100
Why?
Multivariate Analysis
1
2013
853
0.100
Why?
Reference Values
1
2011
305
0.100
Why?
Risk
1
2011
349
0.100
Why?
Neovascularization, Pathologic
2
2010
123
0.090
Why?
Antibody Specificity
2
2007
94
0.090
Why?
Analysis of Variance
1
2011
538
0.090
Why?
Adult
4
2014
13802
0.090
Why?
Female
7
2014
27505
0.090
Why?
Medication Adherence
1
2011
254
0.090
Why?
Immune Tolerance
1
2010
153
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
298
0.080
Why?
Histones
1
2012
438
0.080
Why?
Mice
6
2007
9528
0.080
Why?
Animals
9
2012
18190
0.080
Why?
Hybrid Cells
1
2007
19
0.080
Why?
HIV Infections
1
2014
863
0.070
Why?
Prevalence
1
2010
1143
0.070
Why?
HLA-A2 Antigen
1
2006
69
0.070
Why?
Immunotoxins
1
2005
7
0.070
Why?
Antibodies, Anti-Idiotypic
1
2005
32
0.070
Why?
Young Adult
2
2012
3818
0.070
Why?
CD4 Antigens
1
2006
151
0.070
Why?
Interleukin-2
1
2005
158
0.060
Why?
Antibody Affinity
1
2004
18
0.060
Why?
Immunoglobulin Variable Region
1
2004
30
0.060
Why?
Adolescent
2
2012
5403
0.060
Why?
Cohort Studies
1
2010
2187
0.060
Why?
Cell Line, Tumor
4
2012
1251
0.060
Why?
Peptide Fragments
1
2005
329
0.060
Why?
Follow-Up Studies
3
2014
1991
0.060
Why?
Risk Assessment
1
2010
1647
0.060
Why?
CD11b Antigen
2
2015
21
0.060
Why?
Peptides
1
2006
512
0.050
Why?
Cell Survival
2
2015
515
0.050
Why?
United States
2
2014
6782
0.050
Why?
Mice, Inbred C57BL
1
2007
2937
0.050
Why?
Prognosis
2
2012
1291
0.040
Why?
Sialic Acid Binding Ig-like Lectin 3
1
2015
1
0.030
Why?
STAT3 Transcription Factor
1
2015
65
0.030
Why?
Neck Dissection
1
2014
6
0.030
Why?
Chemotherapy, Adjuvant
1
2014
82
0.030
Why?
Leukocytes, Mononuclear
1
2015
229
0.030
Why?
Immune System
1
2015
136
0.030
Why?
Tertiary Care Centers
1
2014
83
0.030
Why?
Immunosuppressive Agents
1
2015
266
0.030
Why?
Mice, Inbred BALB C
2
2005
836
0.030
Why?
Surgical Flaps
1
2014
94
0.030
Why?
Flow Cytometry
1
2015
636
0.030
Why?
Monocytes
1
2015
331
0.030
Why?
Phosphorylation
1
2015
800
0.030
Why?
Ribonucleotide Reductases
1
2012
7
0.030
Why?
Radiation, Ionizing
1
2012
16
0.030
Why?
Papillomavirus Infections
1
2014
103
0.030
Why?
Cetuximab
1
2012
9
0.030
Why?
Eye
1
2012
48
0.030
Why?
Hydroxyurea
1
2012
23
0.030
Why?
Fluorouracil
1
2012
38
0.030
Why?
Disease Progression
1
2015
832
0.030
Why?
Cell Transformation, Neoplastic
1
2012
187
0.020
Why?
Cell Proliferation
1
2015
891
0.020
Why?
Alcoholism
1
2014
279
0.020
Why?
DNA Repair
1
2012
200
0.020
Why?
Proto-Oncogene Proteins
1
2012
280
0.020
Why?
Kinetics
1
2012
692
0.020
Why?
Cell Cycle
1
2012
356
0.020
Why?
DNA Damage
1
2012
267
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2010
32
0.020
Why?
Cell Cycle Proteins
1
2012
358
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2012
455
0.020
Why?
Smoking
1
2014
707
0.020
Why?
Gene Expression Profiling
1
2012
652
0.020
Why?
Vascular Endothelial Growth Factor A
1
2010
176
0.020
Why?
Drosophila melanogaster
1
2012
479
0.020
Why?
DNA
1
2012
736
0.020
Why?
Time Factors
1
2014
3237
0.020
Why?
Apoptosis
1
2012
963
0.020
Why?
Proteoglycans
1
2006
33
0.020
Why?
Antibody-Dependent Cell Cytotoxicity
1
2006
27
0.020
Why?
Binding, Competitive
1
2006
101
0.020
Why?
Enterotoxins
1
2006
21
0.020
Why?
Laminin
1
2006
76
0.020
Why?
Drug Combinations
1
2006
121
0.020
Why?
Antigens, Differentiation, T-Lymphocyte
1
2006
81
0.020
Why?
Cancer Vaccines
1
2006
45
0.020
Why?
Hemocyanins
1
2005
23
0.020
Why?
Collagen
1
2006
127
0.020
Why?
Cytotoxicity, Immunologic
1
2006
141
0.020
Why?
Lectins, C-Type
1
2006
73
0.020
Why?
Inovirus
1
2005
2
0.020
Why?
Immunization
1
2006
118
0.020
Why?
Disease Models, Animal
1
2012
1829
0.020
Why?
Hypersensitivity, Delayed
1
2005
20
0.020
Why?
Rabbits
1
2006
296
0.020
Why?
Peptide Library
1
2005
32
0.020
Why?
Immunization, Secondary
1
2005
41
0.020
Why?
Molecular Weight
1
2005
175
0.020
Why?
Complement System Proteins
1
2006
125
0.020
Why?
Adoptive Transfer
1
2005
144
0.020
Why?
Up-Regulation
1
2006
345
0.020
Why?
Lymphocytes
1
2005
177
0.020
Why?
Antigens, CD
1
2006
326
0.020
Why?
Gene Library
1
2004
95
0.020
Why?
Cell Movement
1
2006
400
0.020
Why?
Immunoglobulin G
1
2006
423
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2004
91
0.020
Why?
Interferon-gamma
1
2006
509
0.010
Why?
Adjuvants, Immunologic
1
2005
210
0.010
Why?
Cloning, Molecular
1
2004
352
0.010
Why?
Recombinant Fusion Proteins
1
2005
464
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
436
0.010
Why?
Lymphocyte Activation
1
2006
705
0.010
Why?
Mice, Transgenic
1
2006
1162
0.010
Why?
Recombinant Proteins
1
2004
654
0.010
Why?
Sensitivity and Specificity
1
2004
1001
0.010
Why?
Cell Line
1
2006
1936
0.010
Why?
Reproducibility of Results
1
2004
1376
0.010
Why?
Protein Binding
1
2004
1492
0.010
Why?
Ko's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (205)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_